David is CEO of Rostra Therapeutics bringing more than 35 years of experience in driving commercial success across the global pharmaceutical industry. He began his career in UK sales and marketing roles at Johnson & Johnson before joining Glaxo Wellcome, subsequently GSK. There, he held senior positions across in the UK and the US, spanning global marketing and commercial strategy, business development and R&D portfolio management.

David’d expertise encompasses the commercial development of pipeline assets, from candidate selection through clinical development to global launch and through the product life cycle to patent expiry and beyond.

Since 2016, David has led his own consultancy, providing commercial strategy expertise to small and medium-sized enterprises (SMEs). At Rostra Therapeutics, he is now applying this experience to advance the company’s vision: “To restore health and save lives globally with innovative medicines.” Rostra is pursuing this patient-centred vision through the development of novel medicines for invasive fungal diseases, leveraging a therapeutic small-molecule platform technology.